Medications ›elivaldogene autotemcel

elivaldogene autotemcel

RxCUI 2612527 ingredient

Indicated for · 24

Diagnoses11

Adrenoleukodystrophy X-Linked Intellectual Disability Leukoencephalopathies Intellectual Disability Genetic Diseases, X-Linked Brain Diseases, Metabolic, Inborn Heredodegenerative Disorders, Nervous System Brain Diseases, Metabolic Adrenal Insufficiency Metabolism, Inborn Errors Genetic Diseases, Inborn

Condition families13

Hereditary Central Nervous System Demyelinating Diseases Peroxisomal Disorders Demyelinating Diseases Adrenal Gland Diseases Neurobehavioral Manifestations Endocrine System Diseases Brain Diseases Central Nervous System Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Metabolic Diseases Neurologic Manifestations Nutritional and Metabolic Diseases Nervous System Diseases

Indicated to prevent · 4

Diagnoses0

None named.

Condition families4

Neurologic Manifestations Nervous System Diseases Signs and Symptoms Pathological Conditions, Signs and Symptoms

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.